Back in the 1950s, a bedridden man faced certain death from cancer of the lymph nodes. Tumors the size of oranges had invaded the man’s neck, groin, chest, and abdomen. The patient’s only hope was a new experimental cancer drug called Krebiozen. Three days after initial treatment, the man was out of bed and joking with nurses. As treatment continued, his tumors shrunk in half.
